KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001691102-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | May 19, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
4,656
Total Value
$29,650.08
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF DEVELOPMENT OFFICER | Common Stock | โ | May 17, 2026 | Exercise/Conversion | 1,774 | โ | โ | 228,475 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Common Stock | โ | May 18, 2026 | Sale | 1,108 | $26.76 | $29,650.08 | 227,367 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Restricted Stock Unit | Derivative | May 17, 2026 | Exercise/Conversion | 1,774 | $0.00 | $0.00 | 0 | Direct | โ | View Details |